Keith B Hartman
Overview
Explore the profile of Keith B Hartman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolosnjaj-Tabi J, Just J, Hartman K, Laoudi Y, Boudjemaa S, Alloyeau D, et al.
EBioMedicine
. 2016 Mar;
2(11):1697-704.
PMID: 27014740
Compelling evidence shows that fine particulate matters (PMs) from air pollution penetrate lower airways and are associated with adverse health effects even within concentrations below those recommended by the WHO....
2.
Zavaleta C, Hartman K, Miao Z, James M, Kempen P, Thakor A, et al.
Small
. 2011 May;
7(15):2232-40.
PMID: 21608124
Raman imaging offers unsurpassed sensitivity and multiplexing capabilities. However, its limited depth of light penetration makes direct clinical translation challenging. Therefore, a more suitable way to harness its attributes in...
3.
Kolosnjaj-Tabi J, Hartman K, Boudjemaa S, Ananta J, Morgant G, Szwarc H, et al.
ACS Nano
. 2010 Feb;
4(3):1481-92.
PMID: 20175510
Carbon nanotube (CNT) materials are of special interest as potential tools for biomedical applications. However, available toxicological data concerning single-walled carbon nanotubes (SWNTs) and multiwalled carbon nanotubes (MWNTs) remain contradictory....
4.
Hassan A, Chan B, Tran L, Hartman K, Ananta J, Mackeyev Y, et al.
Contrast Media Mol Imaging
. 2010 Jan;
5(1):34-8.
PMID: 20101755
Gadonanotubes (GNTs), which are powerful new T(1)-weighted MRI contrast agents, were derivatized with serine amino acid substituents to produce water-soluble (2 mg ml(-1)) ser-gadonanotubes (ser-GNs) as magnetic nanoprobes for intracellular...
5.
Mackeyev Y, Hartman K, Ananta J, Lee A, Wilson L
J Am Chem Soc
. 2009 Jun;
131(24):8342-3.
PMID: 19492838
A new Rh(6)(CO)(16)-catalyzed functionalization of gadonanotube MRI probes offers the opportunity to prepare a number of amino acid and peptide derivatized gadonanotubes under RT conditions, containing, for example, the cyclic...
6.
Ashcroft J, Gu W, Zhang T, Hughes S, Hartman K, Hofmann C, et al.
Chem Commun (Camb)
. 2008 May;
(21):2471-3.
PMID: 18491018
This communication reports the development of a TiO2-streptavidin nanoconjugate as a new biological label for X-ray bio-imaging applications; this new probe, used in conjunction with the nanogold probe, will make...
7.
Hartman K, Wilson L, Rosenblum M
Mol Diagn Ther
. 2008 Feb;
12(1):1-14.
PMID: 18288878
Nanotechnology offers many opportunities for enhanced diagnostic and therapeutic medicine against cancer and other diseases. In this review, the special properties that result from the nanoscale size of quantum dots,...
8.
Hartman K, Wilson L
Adv Exp Med Biol
. 2008 Jan;
620:74-84.
PMID: 18217336
Over the last several years, great interest has developed in the potential use of carbon nanostructures (C60 fullerenes and nanotubes) in medicine. In some cases, medical agents derived from these...
9.
Hartman K, Laus S, Bolskar R, Muthupillai R, Helm L, Toth E, et al.
Nano Lett
. 2008 Jan;
8(2):415-9.
PMID: 18215084
With their nanoscalar, superparamagnetic Gd(3+)-ion clusters (1 x 5 nm) confined within ultrashort (20-80 nm) single-walled carbon nanotube capsules, gadonanotubes are high-performance T1-weighted contrast agents for magnetic resonance imaging (MRI)....
10.
Hartman K, Hamlin D, Wilbur D, Wilson L
Small
. 2007 Aug;
3(9):1496-9.
PMID: 17668431
No abstract available.